Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivoDana M. Brantley, Jin Chen, Erin J Thompson et al.|Oncogene|2002Cited by 317
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolutionAbdel Hosein, Rolf A. Brekken|JCI Insight|2019Cited by 281
Sitravatinib potentiates immune checkpoint blockade in refractory cancer modelsWenting Du, Rolf A. Brekken|JCI Insight|2018Cited by 111
Phosphorylation of Akt and ERK1/2 Is Required for VEGF-A/VEGFR2-Induced Proliferation and Migration of Lymphatic EndotheliumMichael T. Dellinger, Rolf A. Brekken|PLoS ONE|2011Cited by 99
Targeting TGFβR2‐mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancerHuocong Huang, Rolf A. Brekken|EMBO Molecular Medicine|2019Cited by 87